A Rare Heterozygous TINF2 Deletional Frameshift Mutation in a Chinese Pedigree With a Spectrum of TBDs Phenotypes

Hai-Long Ren; Ying-Chun Zheng; Guo-Qian He; Ju Gao; Xia Guo

doi:10.3389/fgene.2022.913133

A Rare Heterozygous TINF2 Deletional Frameshift Mutation in a Chinese Pedigree With a Spectrum of TBDs Phenotypes

Front Genet. 2022 Jul 7:13:913133. doi: 10.3389/fgene.2022.913133. eCollection 2022.

Authors

Hai-Long Ren¹, Ying-Chun Zheng², Guo-Qian He^{3

4}, Ju Gao^{3

4}, Xia Guo^{3

4}

Affiliations

¹ Division of Spinal Surgery, Department of Orthopaedics, Nanfang Hospital, Southern Medical University, Guangzhou, China.
² Department of Medical Genetics, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
³ Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, China.
⁴ NHC Key Laboratory of Chronobiology, Sichuan University, Chengdu, China.

Abstract

Telomere biology disorders (TBDs) induced by TINF2 mutations manifest clinically with a spectrum of phenotypes, from silent carriers to a set of overlapping conditions. A rare TINF2 frameshift mutation (c.591delG) encoding a truncated mutant TIN2 protein (p.W198fs) was identified in a 6-years-and-3-month-old Chinese girl with neuroblastoma (NB) by next generation sequencing and confirmed by Sanger sequencing. To explore the possible implications of TINF2 mutations in TBDs development, the TINF2 mutant was transfected into the human embryonic kidney (HEK) 293T cells, and mRNA expression of the shelterin complex components as well as the cellular distribution of mutant TIN2 were examined. The TINF2 mutation was phenotypically associated with short stature in the proband, nail dystrophy and spotted hypopigmentation in her mother, and psoriasis in her older brother. I-TASSER modeling analysis revealed conformational changes of the mutant TIN2 protein and loss of pivotal domains downstream of the 198th amino acid. Additionally, mRNA expression of the shelterin components was downregulated, and TIN2 mutant protein expression was reduced in HEK293T cells transfected with mutant TINF2. Furthermore, instead of being restricted to the nucleus, the mutant TIN2 was identified in both the cytoplasm and the nucleus. The TINF2 gene mutation might impair the function of the shelterin complex and the telomere maintenance mechanisms, both of which are involved in the development of TBDs. TBDs have been associated with increased cancer risk. To the best of our knowledge, this is the first report of NB in patients with TBDs. The relationship between the TINF2 mutation and NB may need to further study.

Keywords: TINF2; mutation; neuroblastoma; phenotypes; telomere biology disorders.